BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11737130)

  • 1. The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare.
    Joseph AK; Mark TL; Mueller C
    Dermatol Surg; 2001 Nov; 27(11):955-9. PubMed ID: 11737130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin cancer is among the most costly of all cancers to treat for the Medicare population.
    Housman TS; Feldman SR; Williford PM; Fleischer AB; Goldman ND; Acostamadiedo JM; Chen GJ
    J Am Acad Dermatol; 2003 Mar; 48(3):425-9. PubMed ID: 12637924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonmelanoma skin cancer: an episode of care management approach.
    Housman TS; Williford PM; Feldman SR; Teuschler HV; Fleischer AB; Goldman ND; Balkrishnan R; Chen GJ
    Dermatol Surg; 2003 Jul; 29(7):700-11. PubMed ID: 12828693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician specialty cost differences of treating nonmelanoma skin cancer.
    Chirikov VV; Stuart B; Zuckerman IH; Christy MR
    Ann Plast Surg; 2015 Jan; 74(1):93-9. PubMed ID: 24503881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment patterns and cost of nonmelanoma skin cancer management.
    John Chen G; Yelverton CB; Polisetty SS; Housman TS; Williford PM; Teuschler HV; Feldman SR
    Dermatol Surg; 2006 Oct; 32(10):1266-71. PubMed ID: 17034377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of nonmelanoma skin cancer in the Medicare population.
    Manternach T; Housman TS; Williford PM; Teuschler H; Fleischer AB; Feldman SR; Chen GJ
    Dermatol Surg; 2003 Dec; 29(12):1167-9; discussion 1169. PubMed ID: 14725656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence estimate of nonmelanoma skin cancer in the United States, 2006.
    Rogers HW; Weinstock MA; Harris AR; Hinckley MR; Feldman SR; Fleischer AB; Coldiron BM
    Arch Dermatol; 2010 Mar; 146(3):283-7. PubMed ID: 20231499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of nonmelanoma skin cancer treatment in the United States.
    Chen JG; Fleischer AB; Smith ED; Kancler C; Goldman ND; Williford PM; Feldman SR
    Dermatol Surg; 2001 Dec; 27(12):1035-8. PubMed ID: 11849266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No end in sight: the skin cancer epidemic continues.
    Donaldson MR; Coldiron BM
    Semin Cutan Med Surg; 2011 Mar; 30(1):3-5. PubMed ID: 21540015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of a history of skin cancer in 2007: results of an incidence-based model.
    Stern RS
    Arch Dermatol; 2010 Mar; 146(3):279-82. PubMed ID: 20231498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age distribution of patients with advanced non-melanoma skin cancer in the United States.
    Dacosta Byfield S; Chen D; Yim YM; Reyes C
    Arch Dermatol Res; 2013 Nov; 305(9):845-50. PubMed ID: 23604961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011.
    Guy GP; Machlin SR; Ekwueme DU; Yabroff KR
    Am J Prev Med; 2015 Feb; 48(2):183-187. PubMed ID: 25442229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and economic burden of nonmelanoma skin cancer.
    Cakir BÖ; Adamson P; Cingi C
    Facial Plast Surg Clin North Am; 2012 Nov; 20(4):419-22. PubMed ID: 23084294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-melanoma skin cancer in Australia.
    Fransen M; Karahalios A; Sharma N; English DR; Giles GG; Sinclair RD
    Med J Aust; 2012 Nov; 197(10):565-8. PubMed ID: 23163687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of skin cancer treatment and costs in the United States Medicare population, 1996-2008.
    Rogers HW; Coldiron BM
    Dermatol Surg; 2013 Jan; 39(1 Pt 1):35-42. PubMed ID: 23199014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the health care costs of non-melanoma skin cancer in Saskatchewan using physician billing data.
    Tran DA; Coronado AC; Sarker S; Alvi R
    Curr Oncol; 2019 Apr; 26(2):114-118. PubMed ID: 31043813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of cancer-related physician services to Medicare.
    Maroongroge S; Kim SP; Mougalian S; Johung K; Decker RH; Soulos PR; Long JB; Gross CP; Yu JB
    Yale J Biol Med; 2015 Jun; 88(2):107-14. PubMed ID: 26029009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany.
    Stang A; Stausberg J; Boedeker W; Kerek-Bodden H; Jöckel KH
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):65-72. PubMed ID: 18181975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin cancer (Basal cell carcinoma, squamous cell carcinoma, and malignant melanoma): new cases, treatment practice, and health care costs in new brunswick, Canada, 2002-2010.
    Pilgrim W; Hayes R; Hanson DW; Zhang B; Boudreau B; Leonfellner S
    J Cutan Med Surg; 2014 Oct; 18(5):320-31. PubMed ID: 25186993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.